Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-01-24T05:26:38.788Z Has data issue: false hasContentIssue false
  • English
  • Français

Decision-making for Carotid Endarterectomy. The Trials are Only the Start

Published online by Cambridge University Press:  02 December 2014

H.J.M. Barnett
H.J.M. Barnett*
Affiliation:
King City, ON
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 29 , Issue 4 , November 2002 , pp. 302 - 304
Copyright
Copyright © The Canadian Journal of Neurological 2002

References

1. Taylor, DW, Barnett, HJM, Haynes, RB, et al, for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial. Lancet 1999;353:2179–2184.Google Scholar
2. Barnett, HJM, Meldrum, HE, Eliasziw, M. The appropriate use of carotid endarterectomy. CMAJ 2002;166:1169–1179.Google Scholar
3. Benavente, O, Eliasziw, M, Streifler, JY, et al, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. Prognosis after transient monocular blindness associated with carotid artery stenosis. N Engl J Med 2001;345:1084–1090.CrossRefGoogle ScholarPubMed
4. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995:273:1421–1428.Google Scholar
5. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991;325:445–453.CrossRefGoogle Scholar
6. Inzitari, D, Eliasziw, M, Gates, P, et al, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. The causes and risk of stroke in subjects with an asymptomatic internal carotid artery. N Engl J Med 2000;342:1693–1700.Google Scholar
7. Findlay, JM, Nykolyn, L, Lubkey, TB, et al. Auditing carotid endarterectomy: a regional experience. Can J Neurol Sci 2002;29: 326–332.Google Scholar
8. Barnett, HJM, Eliasziw, M, Meldrum, HE. The prevention of ischemic stroke. BMJ 1999;318:1539–1543.Google Scholar
9. Kresowik, TF, Bratzler, D, Karp, HR, et al. Multistate utilization, processes, and outcomes of carotid endarterectomy. J Vasc Surg 2001;33:227–235.Google Scholar
10. Rothwell, PM, Slattery, W, Warlow, CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 1996;27:260–265.Google Scholar
11. Feasby, TE, Quan, H, Ghali, WA. Provincial carotid endarterectomy outcomes. Can J Neurol Sci 2002;29: 333–336.Google Scholar
12. Barnett, HJM, Eliasziw, M, Meldrum, HE. Correction to BMJ 1999; 318: 1539-1543. Prevention of ischemic stroke. BMJ 1999;319: 626.Google Scholar
13. Alamowitch, S, Eliasziw, M, Taylor, DW, et al, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET), and the ASA and Carotid Endarterectomy (ACE) Trial Collaborators. The risk and benefit of endarterectomy in women with symptomatic internal carotid artery disease. 2002;(In Press).Google Scholar
14. Barnett, HJM, Taylor, DW, Eliasziw, M, et al, for the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in symptomatic patients with moderate and severe stenosis. N Engl J Med 1998;339:1415–1425.CrossRefGoogle ScholarPubMed